Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (DRKS00038030) titled 'German ATTR Amyloidosis Registry' on Oct. 1.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: Prognosis
Primary Sponsor: Klinik III fur Innere Medizin, Herzzentrum, Universitatsklinik Koln
Condition:
E85
Amyloidosis
Intervention:
Group 1: Observational group of data which are assesed in clinical routine in the context of ATTR amyloidosis in the treating center. This comprises comorbidity and histotry of amyloidosis symptoms and manifestations at baseline, and a cardiological assessment including symtoms, lab results, imaging, ECG, treatments and cardiovasc...